Oronza Antonietta Botrugno

8PUBLICATIONS
64CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 12, 2026
N-glycans in non-malignant tumor microenvironment cells dampen CAR-T cell function in solid tumors.

|May 04, 2026
The histone methyltransferase NSD3 oncogene triggers ribosomal DNA transcription, interfering with FOSL2 in cancer.

|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Martina Spiga, Alessia Potenza, Zulma Magnani

|May 28, 2025
Systemic delivery of cadherin 17-specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases.

|Feb 03, 2025
Early tolerance and late persistence as alternative drug responses in cancer.

Simona Punzi, Davide Cittaro, Guido Gatti

|May 02, 2024
Scalable integration of multiomic single-cell data using generative adversarial networks.

Valentina Giansanti, Francesca Giannese, Oronza A Botrugno

Pageof 2

Frequent Collaborators

7 joint publications

Giovanni Tonon

4 joint publications

Davide Cittaro

3 joint publications

Valentina Giansanti

3 joint publications

Chiara Bonini